Department of Pharmaceutics, Jamia Hamdard, New Delhi, India.
Curr Drug Deliv. 2012 Sep;9(5):515-26. doi: 10.2174/156720112802650644.
In the present study an attempt has been made to load Poly (Lactic-Co-glycolic acid) microspheres with hydroxyapatite (HA) and ofloxacin and propose the composite microspheres to be used as local drug delivery system with the drug releasing capability for periodontitis treatment. A modified single emulsion method has been used for the preparation of microspheres. Experiments were conducted to optimize the formulation by RSM-Box-Behnken Method, which is an independent quadratic design involving three or four independent variables against a pre determined set of dependant parameters. The particle size of composite microspheres was analyzed and the average size was found to be 22.05 μm. Photomicrographs and scanning electron micrographs showed that the composite microspheres are spherical in shape and porous in nature. The microbiological activity of optimized formulation was evaluated using strain: S. aureus-ATCC- 29213 and E. coli-ATCC-25922. In vivo/in situ toxicity evaluation of the formulation was assessed by MTT assay and the formulation was found to be biocompatible.
在本研究中,尝试将聚(乳酸-共-乙醇酸)微球负载羟基磷灰石(HA)和氧氟沙星,并提出将复合微球用作局部药物递送系统,具有治疗牙周炎的药物释放能力。采用改良的单乳液法制备微球。通过响应面法-Box-Behnken 方法进行实验,以优化配方,该方法是一种涉及三个或四个独立变量的独立二次设计,针对预定的一组依赖参数。分析了复合微球的粒径,平均粒径为 22.05 μm。光镜和扫描电镜照片显示,复合微球呈球形,具有多孔性。使用菌株:金黄色葡萄球菌-ATCC-29213 和大肠杆菌-ATCC-25922 评估优化配方的微生物活性。通过 MTT 测定评估配方的体内/原位毒性,结果表明该配方具有生物相容性。